For example, in the context of Tauopathies, RAP-MS with the endogenous Tau pre-mRNA can be applied to directly unveil the deregulated RBPs that natively interact with Tau pre-mRNA in post-mortem brain tissues collected from tauopathy patients. This evidence concerns the gene MAPT and tauopathy.